UBS Group’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $694K | Sell |
|
|||||
|
2025
Q3 | $673K | Buy |
|
|||||
|
2025
Q2 | $301K | Buy |
|
|||||
|
2025
Q1 | $320K | Buy |
|
|||||
|
2024
Q4 | $77.3K | Buy |
|
|||||
|
2024
Q3 | $28.5K | Sell |
|
|||||
|
2024
Q2 | $31K | Buy |
|
|||||
|
2024
Q1 | $22.4K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $535 | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $12.2K | Buy |
|
|||||
|
2022
Q4 | $2.31K | Sell |
|
|||||
|
2022
Q3 | $8K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1K | Sell |
|
|||||
|
2021
Q4 | $38K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $61K | Buy |
|